Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 441 - 448 of 12016 results
Department of Homeland Security Designates Lebanon for TPS and Provides for DED-EAD Application
November 27, 2024| Alert| Viewpoint
Telephone and Texting Compliance News — November 2024
November 27, 2024| Article| Viewpoint
Telephone and Texting Compliance News: Regulatory Update — Federal Communications Commission Allows Third-Party Call Authentication
November 27, 2024| Article| Viewpoint
Telephone and Texting Compliance News: Litigation Update — A Win for TCPA Compliance and the Lead Generation Industry
November 27, 2024| Article| Viewpoint
GOP Election Sweep Threatens Niche College Tax Break
November 27, 2024| News
Energy & Sustainability Washington Update — December 2024
November 26, 2024| Article| Viewpoint
Nebraska’s Consumer Privacy Law Takes Effect Soon and Targets Businesses Selling Personal Data
November 26, 2024| Blog| Viewpoint
Massachusetts Supreme Judicial Court Upholds Trustee’s Adjustment from Principal to Income
November 26, 2024| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|